Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

355
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
355

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline characteristics, treatment patterns, and long-term outcomes in patients with eosinophilic esophagitis initiating dupilumab in routine clinical practice: study protocol of a phase IV, prospective, observational, multicenter registry (EDESIA).

Therapeutic advances in gastroenterology·2026
Same author

Associations between maternal injury and adverse perinatal outcomes: evidence from a retrospective cohort study.

American journal of obstetrics & gynecology MFM·2026
Same author

Estimating the association of hypertensive disorders of pregnancy with offspring kidney function from adolescence into young adulthood.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Prevalence and Costs of Non-esophageal Eosinophilic Gastrointestinal Diseases in the United States.

Digestive diseases and sciences·2026
Same author

Prevalence of diagnosed idiopathic hypersomnia among adults in the United States 2019-2023: analysis of healthcare claims.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Postpartum as a Window of Opportunity to Improve Women's Cardiovascular Health.

Hypertension (Dallas, Tex. : 1979)·2026

Related Experiment Video

Updated: Nov 4, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K

Type 2 Diabetes in Youth.

Goutham Rao1, Elizabeth T Jensen2

  • 1University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH, USA.

Global Pediatric Health
|May 26, 2021
PubMed
Summary
This summary is machine-generated.

Type 2 diabetes is rising in US children, progressing faster than type 1. Liraglutide, a GLP-1 agonist, shows promise as a second-line therapy for pediatric type 2 diabetes management.

Keywords:
type 2 diabetes children adolescents

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.0K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.7K

Related Experiment Videos

Last Updated: Nov 4, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.0K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.7K

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • The incidence of type 2 diabetes in US children and adolescents increased by 4.8% annually from 2002-2015.
  • Type 2 diabetes exhibits more aggressive progression and complications compared to type 1 diabetes in pediatric populations.

Purpose of the Study:

  • To review the current landscape of type 2 diabetes in children and adolescents.
  • To discuss screening, diagnosis, and management strategies, including emerging therapies.

Main Methods:

  • Literature review of epidemiological studies and clinical trials.
  • Analysis of current screening guidelines and diagnostic approaches.
  • Evaluation of treatment outcomes for lifestyle interventions and pharmacotherapies.

Main Results:

  • Screening is recommended for children aged 10+ with BMI ≥85th percentile and risk factors.
  • HbA1C is the preferred screening method; autoantibody testing is crucial for differentiating diabetes types.
  • Lifestyle interventions show limited success but are recommended; Liraglutide is an approved second-line therapy.

Conclusions:

  • Early screening and accurate diagnosis are vital for managing pediatric type 2 diabetes.
  • While lifestyle changes are foundational, pharmacotherapy like Liraglutide offers a valuable treatment option.
  • Further research into effective interventions for this growing pediatric health issue is warranted.